NCT00815906 - Study Evaluating Single Doses Of SBI-087 In Japanese Subjects With Rheumatoid Arthritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

April 30, 2012

Study Completion Date

May 31, 2012

Conditions

Arthritis, Rheumatoid

Interventions

DRUG

SBI-087

IV, Single dose

DRUG

SBI-087

IV, Single dose

DRUG

SBI-087

SC, Single dose

DRUG

SBI-087

SC, Single dose

Trial Locations (7)

Pfizer Investigational Site, Ehime

Pfizer Investigational Site, Fukui

Pfizer Investigational Site, Kanagawa

Pfizer Investigational Site, Miyagi

Pfizer Investigational Site, Ōita

Pfizer Investigational Site, Shizuoka

Pfizer Investigational Site, Tokyo